Minimal Residual Disease
978-613-0-06564-5
6130065647
92
2010-07-26
287.64 HK$
eng
https://images.our-assets.com/cover/230x230/9786130065645.jpg
https://images.our-assets.com/fullcover/230x230/9786130065645.jpg
https://images.our-assets.com/cover/2000x/9786130065645.jpg
https://images.our-assets.com/fullcover/2000x/9786130065645.jpg
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online.Minimal residual disease (MRD) is the name given, to small numbers of leukaemic cells that remain in the patient during treatment, or after treatment when the patient is in remission (no symptoms or signs of disease). It is the major cause of relapse in cancer and leukaemia. Up until a decade ago none of the tests used to assess/detect cancer, were sensitive enough to detect MRD. Now, however, very sensitive molecular biology tests are available - based on DNA, RNA or Proteins - and these can measure minute levels of cancer cells in tissue samples, sometimes as low as 1 cancer cell in million normal cells.In cancer treatment, particularly leukaemia, MRD testing has several important roles: determining whether treatment has eradicated the cancer or whether traces remain, comparing the efficacy of different treatments, monitoring patient remission status and recurrence of the leukaemia or cancer and choosing the treatment that will best meet those needs (personalization of treatment)The tests are not simple, are often part of research or trials, and some have been accepted for routine clinical use.
https://www.morebooks.de/books/gb/published_by/alphascript-publishing/2/products
Medicine
https://www.morebooks.de/store/gb/book/minimal-residual-disease/isbn/978-613-0-06564-5